E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
Autonomic dysfunction and HPV immunization: an overview.
Blitshteyn, Svetlana, Brinth, Louise, Hendrickson, Jeanne E et al. · Immunologic research · 2018 · DOI
Quick Summary
This review looked at case reports from multiple countries describing people who developed serious symptoms after HPV vaccination, including extreme fatigue, pain, dizziness, and cognitive problems. These symptoms are similar to those seen in ME/CFS, POTS, and other conditions. The authors suggest that in some genetically vulnerable people, the vaccine might trigger an immune system response that affects the nervous system, but they emphasize that timing alone doesn't prove the vaccine caused the illness.
Why It Matters
This work is important because it documents a pattern of post-vaccination symptom clusters that overlap significantly with ME/CFS presentations and calls for systematic investigation. Understanding whether and how vaccines might trigger ME/CFS-like illness in vulnerable populations could inform both vaccine safety monitoring and personalized medicine approaches for at-risk individuals.
Observed Findings
- Case reports from multiple countries describe similar symptom clusters following HPV vaccination, including disabling fatigue, headache, widespread pain, orthostatic intolerance, gastrointestinal dysfunction, and cognitive impairment.
- These symptom clusters have been labeled with various diagnoses including ME/CFS, POTS, CRPS, small fiber neuropathy, and fibromyalgia.
- Evidence of autoimmunity and autoantibodies exists in subsets of patients with CRPS, POTS, SFN, ME/CFS, and fibromyalgia.
- Given the overlap in symptom presentations, the authors propose a common pathway of vaccine-triggered immune-mediated autonomic dysfunction.
Inferred Conclusions
- Vaccine-triggered, immune-mediated autonomic dysfunction could lead to post-HPV vaccination syndrome in genetically susceptible individuals.
- Mounting case series evidence warrants well-designed case-control studies to determine prevalence and possible causal relationships.
- Personalized medicine approaches using pharmacogenetics and adversomics may eventually help identify individuals predisposed to HPV vaccine adverse events.
Remaining Questions
- What is the actual prevalence of post-HPV vaccination symptom clusters in vaccinated populations compared to unvaccinated controls?
- Which genetic or immunological factors predispose individuals to developing these symptom clusters following HPV vaccination?
What This Study Does Not Prove
This review does not establish that HPV vaccines cause ME/CFS or autonomic dysfunction—it is a descriptive case series review, not an epidemiological study. The authors explicitly note that temporal relationship between vaccination and symptom onset does not prove causation. The review cannot determine prevalence rates, identify causal mechanisms, or quantify actual risk in vaccinated populations.
Tags
Symptom:Cognitive DysfunctionOrthostatic IntolerancePainFatigueSensory Sensitivity
Biomarker:Autoantibodies
Method Flag:PEM Not DefinedNo ControlsExploratory Only
Metadata
- DOI
- 10.1007/s12026-018-9036-1
- PMID
- 30478703
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →